Layman’s summary: There is the potential for a blood screening for kidney disease.
Publication date: July 2011
Published in: Nature Medicine
Lead author: Changli Wei
Department of Medicine, Miller School of Medicine
University of Miami

Abstract: Focal segmental glomerulosclerosis (FSGS) is a cause of proteinuric kidney disease, compromising both native and transplanted kidneys. Treatment is limited because of a complex pathogenesis, including unknown serum factors. Here we report that serum soluble urokinase receptor (suPAR) is elevated in two-thirds of subjects with primary FSGS, but not in people with other glomerular diseases.

>>> More


suPar blood screen for black populations


Dr. Jochen Reiser’s video presentation